Implant device release agents and methods of using same
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
B29C-033/62
B29C-041/08
A61L-027/52
A61L-027/54
출원번호
US-0109852
(2008-04-25)
등록번호
US-9120249
(2015-09-01)
발명자
/ 주소
Kuzma, Petr
Decker, Stephanie
Quandt, Harry
출원인 / 주소
ENDO PHARMACEUTICALS SOLUTIONS INC.
대리인 / 주소
RatnerPrestia
인용정보
피인용 횟수 :
0인용 특허 :
34
초록▼
Medical implant devices are prepared from a polymeric material and a release agent, where the device is a molded, reservoir implant, and the release agent has a molecular weight (MW) of at least 1000. The release agent may be a non-ionic surfactant such as Brij 35, polyoxyetheylene(20)sorbitan triol
Medical implant devices are prepared from a polymeric material and a release agent, where the device is a molded, reservoir implant, and the release agent has a molecular weight (MW) of at least 1000. The release agent may be a non-ionic surfactant such as Brij 35, polyoxyetheylene(20)sorbitan trioleate, Tween 20, Tween 80, vitamin E TPGS, and a mixture of any two or more thereof. Hydrated implants may have a surface area of about 500 mm2 or greater.
대표청구항▼
1. A device suitable for implantation into a subject for delivery of an active agent to the subject at a zero-order or near-zero order rate comprising: a polymeric material comprising a polymer formed from one or more hydrophilic, ethylenically unsaturated monomers and a release agent;wherein the de
1. A device suitable for implantation into a subject for delivery of an active agent to the subject at a zero-order or near-zero order rate comprising: a polymeric material comprising a polymer formed from one or more hydrophilic, ethylenically unsaturated monomers and a release agent;wherein the device is a molded, reservoir implant comprising a hollow core for containing the active agent and an optional pharmaceutical carrier; andthe release agent comprises d-α-tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS). 2. The device of claim 1, wherein the reservoir implant is a dry implant. 3. The device of claim 2, wherein the dry implant has a surface area of about 350 mm2 or greater. 4. The device of claim 2, wherein the dry implant has a surface area of from about 350 mm2 to about 600 mm2. 5. The device of claim 1, wherein the reservoir implant is a hydrated implant. 6. The device of claim 5, wherein the hydrated implant has a surface area of about 500 mm2 or greater. 7. The device of claim 5, wherein the hydrated implant has a surface area of from about 500 mm2 to about 800 mm2. 8. The device of claim 1, wherein the polymeric material is prepared from a monomer mixture comprising two or more polymerizable monomers. 9. The device of claim 8, wherein the monomers are selected from 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, hydroxypropyl methacrylate, hydroxypropyl acrylate, hydroxybutyl methacrylate, hydroxybutyl acrylate, diethylene glycol methacrylate, diethylene glycol acrylate, propylene glycol methacrylate, propylene glycol acrylate, dipropylene glycol methacrylate, dipropylene glycol acrylate, glycidyl methacrylate, glycidyl acrylate, glyceryl methacrylate, glyceryl acrylate, N-methylmethacrylamide, N,N-dimethylmethacrylamide, N-vinylpyrrolidone N-vinylmethylpyrrolidone, N-vinylcaprolactam, N-vinyl-2-methylcaprolactam, N-vinyl-3,5-dimethylcaprolactam, or a mixture of any two or more thereof. 10. The device of claim 8, wherein the monomers are selected from methyl acrylate, methyl methacrylate, ethyl acrylate, ethyl methacrylate, propyl methacrylate, butyl acrylate, butyl methacrylate, methoxymethyl acrylate, methoxymethyl methacrylate, ethoxymethyl acrylate, ethoxymethyl methacrylate, methoxyethyl methacrylate, vinyl acetate, vinyl propionate, or a mixture of any two or more thereof. 11. The device of claim 8, wherein the polymerizable monomers are liquids. 12. A process comprising: charging a polymerization column or a mold with a liquid comprising one or more hydrophilic, ethylenically unsaturated monomers and a release agent;rotating the polymerization column or mold about its longitudinal axis at a speed sufficient to displace the monomer radially outward along the interior surfaces of the polymerization column or mold;maintaining the polymerization column or mold at a position substantially parallel to the ground;polymerizing the liquid polymerizable material; andrecovering a reservoir implant device;wherein the release agent is Vitamin E TPGS. 13. The process of claim 12, wherein the reservoir implant is a dry implant. 14. The process of claim 13, wherein the dry implant has a surface area of about 350 mm2 or greater. 15. The process of claim 13, wherein the dry implant has a surface area of from about 350 mm2 to about 600 mm2. 16. The process of claim 12, wherein the reservoir implant is a hydrated implant. 17. The process of claim 16, wherein the hydrated implant has a surface area of about 500 mm2 or greater. 18. The process of claim 16, wherein the hydrated implant has a surface area of from about 500 mm2 to about 800 mm2. 19. The process of claim 12, wherein the liquid comprises two or more polymerizable monomers. 20. The process of claim 12, wherein the polymerization column or mold is further charged with a free-radical polymerization catalyst selected from organic peroxides, percarbonates, peroxycarbonates, peroxydicarbonates, hydroperoxides, alkali metal sulfates, benzoin methyl ether, or a mixture of any two or more thereof.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (34)
Edwards Bill R. (10311 Merton St. Wichita KS 67209), Acrylic resin composition.
Ayer Atul D. (Palo Alto CA) Burkoth Terry L. (Palo Alto CA) Kuczynski Anthony L. (Palo Alto CA) Deters Joseph C. (Napa CA), Controlled release dispenser comprising beneficial agent.
Szycher Michael (Lynnfield MA), Extrudable polyurethane for prosthetic devices prepared from a diisocyanate, a polytetramethylene ether polyol, and 1,4-.
Moro Daniel G. (Randolph NJ) Ronel Samuel H. (Princeton NJ) Kuzma Petr (Monmouth Junction NJ), Hydrophilic composite polymer articles formed from a settable paste comprising a mixture of hydrophilic polymer and unsa.
Moro Daniel G. (Randolph NJ) Kuzma Petr (Monmouth Junction NJ) Quandt Harry (North Middletown NJ), Manufacture of water-swellable hydrophilic articles and drug delivery devices.
Ronel Samuel H. (Princeton NJ) D\Andrea Mark J. (Neshanic Station NJ) Dobelle William H. (New York NY) Klomp Gregory F. (New York NY) Hashiguchi Hiroshi (Riverdale NY), Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue an.
Williams Alan H. (Mount Duneed Via Belmont AUX) Staples Linton D. (East Kew AUX) Thiel William J. (Brighton AUX) Oppenheim Richard C. (Kew AUX) Clarke Iain J. (Malvern East AUX), Subdermal biocompatible implants.
Bodmer David,CHX ; Fong Jones W. ; Kissel Thomas,DEX ; Maulding Hawkins V. ; Nagele Oskar,CHX ; Pearson Jane E., Sustained release formulations of water soluble peptides.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.